A pediatric dermatologist explains how CALM count, size, age, and associated findings separate benign spots from neurofibromatosis type 1 and its mimics.
Advertisement
Advertisement
Trending on Dermatology Times
1
Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients
2
Pediatric Atopic Dermatitis: Skin Barrier Care and Early Biologic Use
3
Litifilimab Improves Cutaneous Lupus Symptoms Through 52 Weeks
4
Gene Expression Profiling May Refine Cutaneous Melanoma Care
5